Abstract
Superior oblique myokymia (SOM) is an ocular motility disorder characterized by oscillopsia, vertical or torsional diplopia, sometimes combined with pressure sensation. Although the pathophysiological basis is unclear, isolated case reports have documented its association with intracranial pathological processes. We present a case of SOM associated with a vascular compression of the fourth nerve at the root exit zone. Following microneurosurgical decompression, SOM completely resolved and paralysis of the fourth nerve occurred. This was less disturbing.
References
1.
Duane A: Unilateral rotary nystagmus. Trans Am Ophthalmol Soc 1906;11:63–67.
2.
Hoyt WF, Keane JR: Superior oblique myokymia. Report and discussion on five cases of benign intermittent uniocular microtremor. Arch Ophthalmol 1970;84:461–467.
3.
Morrow MJ, Sharpe JA, Ranelli PJ: Superior oblique myokymia associated with a posterior fossa tumor. Oculographic correlation with an idiopathic case. Neurology 1990;40:367–370.
4.
De Haene I, Casselman J: Left superior oblique myokymia and right superior oblique paralysis due to a posterior fossa tumor. Neuro-Ophthalmology 1993;13:13–16.
5.
Geis TC, Newman NJ, Dawson RC: Superior oblique myokymia associated with a dural arteriovenous fistula. J Neuro-Ophthalmol 1996;16:41–43.
6.
Neetens A, Martin JJ: Superior oblique myokymia in a case of adrenoleukodystrophy and in a case of lead intoxication. Neuro-Ophthalmology 1983;3:103–107.
7.
Rosenberg ML, Glaser JS: Superior oblique myokymia. Ann Neurol 1983;13:667–669.
8.
Tyler RD, Ruiz RS: Propanolol in the treatment of superior oblique myokymia. Arch Ophthalmol 1990;108:175–176.
9.
Patterson TC, Golsch RA: Superior oblique myokymia: A prism lens approach to control. J Am Optom Assoc 1986;57:896–898.
10.
De Sa LC, Good WV, Hoyt CS: Surgical management of myokymia of the superior oblique muscle. Am J Ophthalmol 1992;114:693–696.
11.
Palmer EA, Shults WT: Superior oblique myokymia: Preliminary results of surgical treatment. J Pediatr Ophthalmol Strabismus 1984;21:96–101.
12.
Møller AR: The cranial nerve vascular compression syndrome: II. A review of pathophysiology. Acta Neurochir 1991;113:24–30.
13.
Bringewald PR: Superior oblique myokymia [letter]. Arch Neurol 1983;40:526.
14.
Kommerell G, Schaubele G: Superior oblique myokymia: An electromyographical analysis. Trans Ophthalmol Soc UK 1980;100:504–506.
15.
Lee JP: Superior oblique myokymia. A possible etiologic factor. Arch Ophthalmol 1984;102:1178–1179.
16.
Brazis PW, Miller NR, Henderer JD, Lee AG: The natural history and results of treatment of superior oblique myokymia. Arch Ophthalmol 1994;112:1063–1067.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.